Not applicableStudy completedNCT02269813
What this trial is testing
PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 452